Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of 3.41 million. The enterprise value is 2.23 million.
| Market Cap | 3.41M |
| Enterprise Value | 2.23M |
Important Dates
The next estimated earnings date is Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.78 million shares outstanding. The number of shares has increased by 26.19% in one year.
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +26.19% |
| Shares Change (QoQ) | +22.05% |
| Owned by Insiders (%) | 6.37% |
| Owned by Institutions (%) | 9.39% |
| Float | 1.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.25 |
| PB Ratio | -0.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.31 |
| EV / Sales | 2.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47
| Current Ratio | 0.47 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -261.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.71% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 181.32% |
| Revenue Per Employee | 105,196 |
| Profits Per Employee | -718,507 |
| Employee Count | 15 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.70 |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.83% in the last 52 weeks. The beta is 0.51, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -86.83% |
| 50-Day Moving Average | 2.95 |
| 200-Day Moving Average | 5.86 |
| Relative Strength Index (RSI) | 34.61 |
| Average Volume (20 Days) | 40,756 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, XAGE had revenue of 1.05 million and -7.19 million in losses. Loss per share was -7.99.
| Revenue | 1.05M |
| Gross Profit | 604,414 |
| Operating Income | -5.79M |
| Pretax Income | -7.28M |
| Net Income | -7.19M |
| EBITDA | -5.71M |
| EBIT | -5.79M |
| Loss Per Share | -7.99 |
Balance Sheet
The company has 1.55 million in cash and 371,435 in debt, giving a net cash position of 1.18 million or 0.66 per share.
| Cash & Cash Equivalents | 1.55M |
| Total Debt | 371,435 |
| Net Cash | 1.18M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | -3.74M |
| Book Value Per Share | -2.52 |
| Working Capital | -3.67M |
Cash Flow
| Operating Cash Flow | -3.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 57.46% |
| Operating Margin | -550.59% |
| Pretax Margin | -692.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.19% |
| Shareholder Yield | n/a |
| Earnings Yield | -210.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 14, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | May 14, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
XAGE has an Altman Z-Score of -32.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -32.46 |
| Piotroski F-Score | 2 |